The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.
Precision Medicine: Disease Subtyping and Tailored Treatment
Open accessAbstract
The genomics-based concept of precision medicine began to emerge following the completion of the Human Genome Project. In contrast to evidence-based medicine, precision medicine will allow doctors and scientists to tailor the treatment of different subpopulations of patients who differ in their susceptibility to specific diseases or responsiveness to specific therapies. The current precision medicine model was proposed to precisely classify patients into subgroups sharing a common biological basis of diseases for more effective tailored treatment to achieve improved outcomes. Precision medicine has become a term that symbolizes the new age of medicine. In this review, we examine the history, development, and future perspective of precision medicine. We also discuss the concepts, principles, tools, and applications of precision medicine and related fields. In our view, for precision medicine to work, two essential objectives need to be achieved. First, diseases need to be classified into various subtypes. Second, targeted therapies must be available for each specific disease subtype. Therefore, we focused this review on the progress in meeting these two objectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
A New Initiative on Precision Medicine
Collins, F. S., & Varmus, H. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500523 · Cited by 5,202
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Big data analytics in healthcare: promise and potential
Raghupathi, W., & Raghupathi, V. (2014) · Health Information Science and Systems · doi:10.1186/2047-2501-2-3 · Cited by 3,034
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.-H., Ito, S., Yang, C., Wang, P., Xiao, M.-T., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.12.014 · Cited by 2,875
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, S., Jacot, W., Yamashita, T., Sohn, J., Vidal, M., Tokunaga, E., Tsurutani, J., Ueno, N. T., Prat, A., Chae, Y. S., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2203690 · Cited by 2,664
Triple-negative breast cancer molecular subtyping and treatment progress
Yin, L., Duan, J.-J., Bian, X.-W., & Yu, S.-C. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01296-5 · Cited by 2,452
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Scott, A. M., Wolchok, J. D., & Old, L. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3236 · Cited by 2,160
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096
Trastuzumab deruxtecan in previously treated HER2-positive breast cancer
Modi, S., Saura, C., Yamashita, T., Park, Y. H., Kim, S.-B., Tamura, K., Andre, F., Iwata, H., Ito, Y., Tsurutani, J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1914510 · Cited by 2,006
A living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
A History of Cancer Chemotherapy
DeVita, V. T., & Chu, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6611 · Cited by 1,970
Exploring tissue architecture using spatial transcriptomics
Rao, A., Barkley, D., França, G. S., & Yanai, I. (2021) · Nature · doi:10.1038/s41586-021-03634-9 · Cited by 1,700
Antibody drug conjugate: the “biological missile” for targeted cancer therapy
Fu, Z., Li, S., Han, S., Shi, C., & Zhang, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00947-7 · Cited by 1,643
Multi-omics Data Integration, Interpretation, and Its Application
Subramanian, I., Verma, S., Kumar, S., Jere, A., & Anamika, K. (2020) · Bioinformatics and Biology Insights · doi:10.1177/1177932219899051 · Cited by 1,609
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Gao, D., Vela, I., Sboner, A., Iaquinta, P. J., Karthaus, W. R., Gopalan, A., Dowling, C., Wanjala, J. N., Undvall, E. A., Arora, V. K., et al. (2014) · Cell · doi:10.1016/j.cell.2014.08.016 · Cited by 1,559
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Broutier, L., Mastrogiovanni, G., Verstegen, M. M., Francies, H. E., Gavarró, L. M., Bradshaw, C. R., Allen, G. E., Arnes-Benito, R., Sidorova, O., Gaspersz, M. P., et al. (2017) · Nature Medicine · doi:10.1038/nm.4438 · Cited by 1,471 · cited 1×
“The identification of the Lgr5+ adult stem cell population within the intestinal crypt [144] and the subsequent development of the growth factor recipe for human intestinal organoids [145] made the development of organoids possible and opened the way to the generation of organoids from many tissues, including the colo…”
BackgroundPaul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Effect of VKORC1 Haplotypes on Transcriptional Regulation and Warfarin Dose
Rieder, M. J., Reiner, A. P., Gage, B. F., Nickerson, D. A., Eby, C. S., McLeod, H. L., Blough, D. K., Thummel, K. E., Veenstra, D. L., & Rettie, A. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044503 · Cited by 1,399
Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
Bianchini, G., De Angelis, C., Licata, L., & Gianni, L. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00565-2 · Cited by 1,382
Aithal, G. P., Day, C. P., Kesteven, P. J., & Daly, A. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)04474-2 · Cited by 1,243
Lowe, R., Shirley, N., Bleackley, M., Dolan, S., & Shafee, T. (2017) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1005457 · Cited by 1,176
Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome
Lötvall, J., Akdis, C. A., Bacharier, L. B., Bjermer, L., Casale, T. B., Custovic, A., Lemanske, R. F., Wardlaw, A. J., Wenzel, S. E., & Greenberger, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.037 · Cited by 1,160
Jacob, F., Salinas, R. D., Zhang, D. Y., Nguyen, P. T. T., Schnoll, J. G., Wong, S. Z. H., Thokala, R., Sheikh, S., Saxena, D., Prokop, S., et al. (2020) · Cell · doi:10.1016/j.cell.2019.11.036 · Cited by 1,149
We can do better―improving the health of the American people
Schroeder, S. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa073350 · Cited by 1,065
Sackett, D. L. (1997) · Seminars in Perinatology · doi:10.1016/s0146-0005(97)80013-4 · Cited by 1,061
Progress in evidence-based medicine: a quarter century on
Djulbegovic, B., & Guyatt, G. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31592-6 · Cited by 1,022 · cited 2×
“In this way, individual clinical expertise will be integrated with the best available external clinical evidence through systematic research [3,4].”
BackgroundDeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Bertotti, A., Migliardi, G., Galimi, F., Sassi, F., Torti, D., Isella, C., Corà, D., Di Nicolantonio, F., Buscarino, M., Petti, C., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0109 · Cited by 939 · cited 1×
“To overcome the limitation, PDXs have been established as a model more likely to mimic human tumors, which makes them a useful tool for translational research [128,129].”
BackgroundAssessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906 · cited 2×
“However, despite these limitations, the organs-on-chips model has great potential to advance functional precision medicine by facilitating the studies of tissue development, organ physiology, and disease etiology, as well as drug discovery and development [158,159,161,162].”
BackgroundPredictive, personalized, preventive, participatory (P4) cancer medicine
Hood, L., & Friend, S. H. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.227 · Cited by 900
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., Zhou, A., Eyob, H., Balakrishnan, S., Wang, C.-Y., et al. (2015) · Nature · doi:10.1038/nature15260 · Cited by 893
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Lee, S. H., Hu, W., Matulay, J. T., Silva, M. V., Owczarek, T. B., Kim, K., Chua, C. W., Barlow, L. J., Kandoth, C., Williams, A. B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.017 · Cited by 873
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross, P. F., Beitz, J. G., Chen, G., Chen, X., Duffy, E. J., Kieffer, L. V., Roy, S., Sridhara, R. N., Rahman, A., Williams, G., et al. (2001) · PubMed · Cited by 855
Monoclonal Antibodies in Cancer Therapy
Zahavi, D., & Weiner, L. (2020) · Antibodies · doi:10.3390/antib9030034 · Cited by 831
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
Bantscheff, M., Lemeer, S., Savitski, M. M., & Kuster, B. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6203-4 · Cited by 801
Genetic Control of Isoniazid Metabolism in Man
Evans, D. A. P., Manley, K. A., & McKusick, V. A. (1960) · BMJ · doi:10.1136/bmj.2.5197.485 · Cited by 784
Proteogenomics: concepts, applications and computational strategies
Nesvizhskii, A. I. (2014) · Nature Methods · doi:10.1038/nmeth.3144 · Cited by 770
Yan, H. H. N., Siu, H. C., Law, S., Ho, S. L., Yue, S. S. K., Tsui, W. Y., Chan, D., Chan, A. S., Ma, S., Lam, K. O., et al. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.09.016 · Cited by 724 · cited 1×
“The identification of the Lgr5+ adult stem cell population within the intestinal crypt [144] and the subsequent development of the growth factor recipe for human intestinal organoids [145] made the development of organoids possible and opened the way to the generation of organoids from many tissues, including the colo…”
BackgroundMetabolomics: an emerging but powerful tool for precision medicine
Clish, C. B. (2015) · Molecular Case Studies · doi:10.1101/mcs.a000588 · Cited by 708
Organ-on-a-chip: recent breakthroughs and future prospects
Wu, Q., Liu, J., Wang, X., Feng, L., Wu, J., Zhu, X., Wen, W., & Gong, X. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-0752-0 · Cited by 701
Small molecules, big impact: 20 years of targeted therapy in oncology
Bedard, P. L., Hyman, D. M., Davids, M. S., & Siu, L. L. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30164-1 · Cited by 610
Biomarker: Predictive or Prognostic?
Ballman, K. V. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3651 · Cited by 522
Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers
Trusheim, M. R., Berndt, E. R., & Douglas, F. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2251 · Cited by 509
Boretto, M., Maenhoudt, N., Luo, X., Hennes, A., Boeckx, B., Bui, B., Heremans, R., Perneel, L., Kobayashi, H., Van Zundert, I., et al. (2019) · Nature Cell Biology · doi:10.1038/s41556-019-0360-z · Cited by 503
Evidence Based Medicine - New Approaches and Challenges
Masic, I., Miokovic, M., & Muhamedagic, B. (2008) · Acta Informatica Medica · doi:10.5455/aim.2008.16.219-225 · Cited by 495
Applications of patient-derived tumor xenograft models and tumor organoids
Yoshida, G. J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0829-z · Cited by 471 · cited 3×
“Accumulated data suggest that the sensitivity to standard chemotherapeutics in PDXs closely correlates with clinical data for patients from which the PDXs are derived [127,130].”
BackgroundMethodDeep phenotyping for precision medicine
Robinson, P. N. (2012) · Human Mutation · doi:10.1002/humu.22080 · Cited by 470
Emerging new therapeutic antibody derivatives for cancer treatment
Jin, S., Sun, Y., Liang, X., Gu, X., Ning, J., Xu, Y., Chen, S., & Pan, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00868-x · Cited by 459
Phenotypes and endotypes of adult asthma: Moving toward precision medicine
Kaur, R., & Chupp, G. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.05.031 · Cited by 457
Mobile technology and the digitization of healthcare
Bhavnani, S. P., Narula, J., & Sengupta, P. P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv770 · Cited by 454
Guillen, K. P., Fujita, M., Butterfield, A. J., Scherer, S. D., Bailey, M. H., Chu, Z., DeRose, Y. S., Zhao, L., Cortes-Sanchez, E., Yang, C.-H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00337-6 · Cited by 416
Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis
Doshi-Velez, F., Ge, Y., & Kohane, I. (2014) · Pediatrics · doi:10.1542/peds.2013-0819 · Cited by 412
Oral Mucosal Organoids as a Potential Platform for Personalized Cancer Therapy
Driehuis, E., Kolders, S., Spelier, S., Lõhmussaar, K., Willems, S. M., Devriese, L. A., de Bree, R., de Ruiter, E. J., Korving, J., Begthel, H., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1522 · Cited by 408
Metabolomics toward personalized medicine
Jacob, M., Lopata, A. L., Dasouki, M., & Abdel Rahman, A. M. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21548 · Cited by 400
AI in Health: State of the Art, Challenges, and Future Directions
Wang, F., & Preininger, A. (2019) · Yearbook of Medical Informatics · doi:10.1055/s-0039-1677908 · Cited by 398
Single-cell multimodal omics: the power of many
Zhu, C., Preissl, S., & Ren, B. (2020) · Nature Methods · doi:10.1038/s41592-019-0691-5 · Cited by 386
Proteomics: Concepts and applications in human medicine
Al-Amrani, S., Al-Jabri, Z., Al-Zaabi, A., Alshekaili, J., & Al-Khabori, M. (2021) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v12.i5.57 · Cited by 374
Big Data Analytics in Medicine and Healthcare
Ristevski, B., & Chen, M. (2018) · Journal of Integrative Bioinformatics · doi:10.1515/jib-2017-0030 · Cited by 373
Baselga, J., Cortés, J., Im, S.-A., Clark, E., Ross, G., Kiermaier, A., & Swain, S. M. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5384 · Cited by 364
Emerging Role of Precision Medicine in Cardiovascular Disease
Leopold, J. A., & Loscalzo, J. (2018) · Circulation Research · doi:10.1161/circresaha.117.310782 · Cited by 362
Proteogenomic mapping as a complementary method to perform genome annotation
Jaffe, J. D., Berg, H. C., & Church, G. M. (2004) · PROTEOMICS · doi:10.1002/pmic.200300511 · Cited by 357
Personalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
The Coming Age of Complete, Accurate, and Ubiquitous Proteomes
Mann, M., Kulak, N. A., Nagaraj, N., & Cox, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.029 · Cited by 350
Individualized Medicine from Prewomb to Tomb
Topol, E. J. (2014) · Cell · doi:10.1016/j.cell.2014.02.012 · Cited by 333
Fior, R., Póvoa, V., Mendes, R. V., Carvalho, T., Gomes, A., Figueiredo, N., & Ferreira, M. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1618389114 · Cited by 320
Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer
Shi, R., Radulovich, N., Ng, C., Liu, N., Notsuda, H., Cabanero, M., Martins-Filho, S. N., Raghavan, V., Li, Q., Mer, A. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1376 · Cited by 316
Li, X., Francies, H. E., Secrier, M., Perner, J., Miremadi, A., Galeano-Dalmau, N., Barendt, W. J., Letchford, L., Leyden, G. M., Goffin, E. K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05190-9 · Cited by 316
Antibody–Drug Conjugates for Cancer Treatment
Lambert, J. M., & Berkenblit, A. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-061516-121357 · Cited by 314
–Omic and Electronic Health Record Big Data Analytics for Precision Medicine
Wu, P.-Y., Cheng, C.-W., Kaddi, C. D., Venugopalan, J., Hoffman, R., & Wang, M. D. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2573285 · Cited by 303
Human Immune Respone to Monoclonal Antibodies
Khazaeli, M. B., Conry, R. M., & LoBuglio, A. F. (1994) · Journal of Immunotherapy · doi:10.1097/00002371-199401000-00006 · Cited by 301
Kondrashova, O., Topp, M., Nesic, K., Lieschke, E., Ho, G.-Y., Harrell, M. I., Zapparoli, G. V., Hadley, A., Holian, R., Boehm, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05564-z · Cited by 296
Letai, A., Bhola, P., & Welm, A. L. (2022) · Cancer Cell · doi:10.1016/j.ccell.2021.12.004 · Cited by 281
Beckmann, J. S., & Lew, D. (2016) · Genome Medicine · doi:10.1186/s13073-016-0388-7 · Cited by 258
Pharmacogenetics and Pharmacogenomics: Development, Science, and Translation
Weinshilboum, R. M., & Wang, L. (2006) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162315 · Cited by 231
Clinical subtypes of Parkinson's disease
van Rooden, S. M., Colas, F., Martínez‐Martín, P., Visser, M., Verbaan, D., Marinus, J., Chaudhuri, R. K., Kok, J. N., & van Hilten, J. J. (2011) · Movement Disorders · doi:10.1002/mds.23346 · Cited by 228
Joint profiling of DNA methylation and chromatin architecture in single cells
Li, G., Liu, Y., Zhang, Y., Kubo, N., Yu, M., Fang, R., Kellis, M., & Ren, B. (2019) · Nature Methods · doi:10.1038/s41592-019-0502-z · Cited by 228
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
Franzin, R., Netti, G. S., Spadaccino, F., Porta, C., Gesualdo, L., Stallone, G., Castellano, G., & Ranieri, E. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.574271 · Cited by 201
Pharmacogenetics of oral anticoagulants
Daly, A. K., & King, B. P. (2003) · Pharmacogenetics · doi:10.1097/00008571-200305000-00002 · Cited by 195
Deep phenotyping: The details of disease
Delude, C. M. (2015) · Nature · doi:10.1038/527s14a · Cited by 191
New and emerging targeted therapies for cystic fibrosis
Quon, B. S., & Rowe, S. M. (2016) · BMJ · doi:10.1136/bmj.i859 · Cited by 185
de Giambattista, C., Ventura, P., Trerotoli, P., Margari, M., Palumbi, R., & Margari, L. (2018) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-018-3689-4 · Cited by 180
Predictive, preventive, personalized and participatory medicine: back to the future
Auffray, C., Charron, D., & Hood, L. (2010) · Genome Medicine · doi:10.1186/gm178 · Cited by 174
Precision medicine: Concept and tools
Naithani, N., Sinha, S., Misra, P., Vasudevan, B., & Sahu, R. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2021.06.021 · Cited by 172
Promises, promises, and precision medicine
Joyner, M. J., & Paneth, N. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126119 · Cited by 171
Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells
Du, J., Su, Y., Qian, C., Yuan, D., Miao, K., Lee, D., Ng, A. H. C., Wijker, R. S., Ribas, A., Levine, R. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18376-x · Cited by 171
Pan, Z., Wang, K., Wang, X., Jia, Z., Yang, Y., Duan, Y., Huang, L., Wu, Z., Zhang, J., & Ding, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01547-3 · Cited by 171
Epigenomics: Technologies and Applications
Wang, K. C., & Chang, H. Y. (2018) · Circulation Research · doi:10.1161/circresaha.118.310998 · Cited by 169
Melanoma drug wins US approval
Ledford, H. (2011) · Nature · doi:10.1038/471561a · Cited by 163
THE RELATION BETWEEN DOSE OF SUCCINYLCHOLINE AND DURATION OF APNEA IN MAN
KALOW, W., & Gunn, D. R. (1957) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11853-3 · Cited by 161
SOME STATISTICAL DATA ON ATYPICAL CHOLINESTERASE OF HUMAN SERUM
KALOW, W., & GUNN, D. R. (1959) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1959.tb01467.x · Cited by 160
Fack, F., Tardito, S., Hochart, G., Oudin, A., Zheng, L., Fritah, S., Golebiewska, A., Nazarov, P. V., Bernard, A., Hau, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707729 · Cited by 160
Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New Trends
Steiner, M., & Neri, D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0483 · Cited by 157
Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy
Talebi, A., Dehairs, J., Rambow, F., Rogiers, A., Nittner, D., Derua, R., Vanderhoydonc, F., Duarte, J. A. G., Bosisio, F., Van den Eynde, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04664-0 · Cited by 155 · cited 1×
“The PDX has been used for many different cancers, including colon adenocarcinoma [1,131], pancreatic cancer [132,133], cholangiocarcinoma [134], glioblastoma [135], glioma [136], medulloblastoma [137], breast carcinoma [130,138,139], lung cancer [140], malignant melanoma [141], head and neck squamous cell carcinoma (H…”
MethodLee, G., Auffinger, B., Guo, D., Hasan, T., Deheeger, M., Tobias, A. L., Kim, J. Y., Atashi, F., Zhang, L., Lesniak, M. S., et al. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0675 · Cited by 142
Method of the Year 2019: Single-cell multimodal omics
(2020) · Nature Methods · doi:10.1038/s41592-019-0703-5 · Cited by 141
B cell targeted therapies in autoimmune disease
Barnas, J. L., Looney, R. J., & Anolik, J. H. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.09.004 · Cited by 138
Subtyping: What It is and Its Role in Precision Medicine
Saria, S., & Goldenberg, A. (2015) · IEEE Intelligent Systems · doi:10.1109/mis.2015.60 · Cited by 129
New Era of Personalized Medicine
Langreth, R., & Waldholz, M. (1999) · The Oncologist · doi:10.1634/theoncologist.4-5-426 · Cited by 127
Liu, J. F., Palakurthi, S., Zeng, Q., Zhou, S., Ivanova, E., Huang, W., Zervantonakis, I. K., Selfors, L. M., Shen, Y., Pritchard, C. C., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1237 · Cited by 127
Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells
Grasset, E. M., Bertero, T., Bozec, A., Friard, J., Bourget, I., Pisano, S., Lecacheur, M., Maiel, M., Bailleux, C., Emelyanov, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0601 · Cited by 126
Precision medicine and management of rheumatoid arthritis
Aletaha, D. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102405 · Cited by 123
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Misale, S., Bozic, I., Tong, J., Peraza-Penton, A., Lallo, A., Baldi, F., Lin, K. H., Truini, M., Trusolino, L., Bertotti, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9305 · Cited by 122
Using Electronic Health Records To Generate Phenotypes For Research
Pendergrass, S. A., & Crawford, D. C. (2019) · Current Protocols in Human Genetics · doi:10.1002/cphg.80 · Cited by 120
Bruun, J., Kryeziu, K., Eide, P. W., Moosavi, S. H., Eilertsen, I. A., Langerud, J., Røsok, B. I., Totland, M. Z., Brunsell, T. H., Pellinen, T. S., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3637 · Cited by 117
Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern
Eggers, C., Pedrosa, D. J., Kahraman, D., Maier, F., Lewis, C. J., Fink, G. R., Schmidt, M., & Timmermann, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046813 · Cited by 106
Emerging Applications of Metabolomics in Clinical Pharmacology
Pang, H., Jia, W. P., & Hu, Z. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1538 · Cited by 105
Genetics and health inequalities: hypotheses and controversies
Mackenbach, J. P. (2005) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2004.026807 · Cited by 98
Time to dissect the autoimmune etiology of cancer antibody immunotherapy
Dougan, M. L., & Pietropaolo, M. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131194 · Cited by 97
Goydel, R. S., & Rader, C. M. (2021) · Oncogene · doi:10.1038/s41388-021-01811-8 · Cited by 97
Personalized medicine—concepts, technologies, and applications in inflammatory skin diseases
Litman, T. (2019) · Apmis · doi:10.1111/apm.12934 · Cited by 95
Rajeshkumar, N. V., Yabuuchi, S., Pai, S. G., Oliveira, E. D., Kamphorst, J. J., Rabinowitz, J. D., Tejero, H., Al‐Shahrour, F., Hidalgo, M. M., Maitra, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1115 · Cited by 90
Information Quality Frameworks for Digital Health Technologies: Systematic Review
Fadahunsi, K. P., O’Connor, S., Akinlua, J. T., Wark, P. A., Gallagher, J., Carroll, C., Car, J., Majeed, A., & O’Donoghue, J. (2021) · Journal of Medical Internet Research · doi:10.2196/23479 · Cited by 85
A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine
Turanlı, B., Karagoz, K., Gülfidan, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612824666181106095959 · Cited by 83
Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy
Jørgensen, J. T. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0054 · Cited by 81
Aghanejad, A., Bonab, S. F., Sepehri, M., Haghighi, F. S., Tarighatnia, A., Kreiter, C., Nader, N. D., & Tohidkia, M. R. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.03.057 · Cited by 74
Defining a comprehensive verotype using electronic health records for personalized medicine
Boland, M. R., Hripcsak, G. M., Shen, Y., Chung, W. K., & Weng, C. (2013) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2013-001932 · Cited by 72
Pharmacoepigenetics: an element of personalized therapy?
Majchrzak‐Celińska, A., & Baer‐Dubowska, W. (2016) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1260546 · Cited by 65
Ayachi, I. E., Fatima, I., Wend, P., Alva-Ornelas, J. A., Runke, S., Kuenzinger, W. L., Silva, J. D. S., Silva, W., Gray, J. K., Lehr, S., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1069 · Cited by 65
Exceptional Opportunities in Medical Science
Collins, F. S. (2015) · JAMA · doi:10.1001/jama.2014.16736 · Cited by 64
Doherty, E. L., Aw, W. Y., Hickey, A. J., & Polacheck, W. J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.624435 · Cited by 61
Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era
Xu, M., Zhang, K., & Song, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.623674 · Cited by 61
Electronic health records: the next wave of complex disease genetics
Wolford, B. N., Willer, C. J., & Surakka, I. L. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy081 · Cited by 59
Evans, M. K., Sauer, S. J., Nath, S., Robinson, T. J., Morse, M. A., & Devi, G. R. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.412 · Cited by 53
Wei, S., Tao, J., Xu, J., Chen, X., Wang, Z., Zhang, N., Zuo, L., Jia, Z., Chen, H., Sun, H., et al. (2021) · Advanced Science · doi:10.1002/advs.202100727 · Cited by 51
Self-citationUnveiling the Human Gastrointestinal Tract Microbiome: The Past, Present, and Future of Metagenomics
Athanasopoulou, K., Adamopoulos, P. G., & Scorilas, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030827 · Cited by 51
Evidence-based medicine and big genomic data
Ioannidis, J. P. A., & Khoury, M. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy065 · Cited by 47
Bioconjugation in Drug Delivery: Practical Perspectives and Future Perceptions
Elzahhar, P. A., Belal, A. S. F., ElAmrawy, F., Helal, N. A., & Nounou, M. I. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9516-5_11 · Cited by 47
Integrative Neuroscience and Personalized Medicine
(2010) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195393804.001.0001 · Cited by 41
Microbiomics: Were we all wrong before?
Kumar, P. (2020) · Periodontology 2000 · doi:10.1111/prd.12373 · Cited by 40
Emerging roles of RAC1 in treating lung cancer patients
Zou, T., Mao, X., Yin, J., Li, X., Chen, J., Zhu, T., Li, Q., Zhou, H., & Liu, Z. (2016) · Clinical Genetics · doi:10.1111/cge.12908 · Cited by 38
Garcia, P. L., Miller, A. L., Gamblin, T. L., Christein, J. D., Arnoletti, J. P., Heslin, M. J., Reddy, S., Richardson, J. H., Cui, X., van Waardenburg, R. C. A. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0922 · Cited by 38
Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics
Mussap, M., Loddo, C., Fanni, C., & Fanos, V. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1713750 · Cited by 38
Emerging EGFR antagonists for breast cancer
Lluch, A. M., Eroles, P., & Fidalgo, J. A. P. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.903919 · Cited by 30
Pharmacoproteomics: a chess game on a protein field
D’Alessandro, A., & Zolla, L. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.10.002 · Cited by 29
Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes
Schrader, S., Perfilyev, A., Martinell, M., García-Calzón, S., & Ling, C. (2021) · Epigenomics · doi:10.2217/epi-2020-0442 · Cited by 29
Stratified medicines: towards better treatment for disease
Bell, J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60115-x · Cited by 27
Counterpoint: Successes in the Pursuit of Precision Medicine: Biomarkers Take Credit
Kato, S., Subbiah, V., & Kurzrock, R. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0127 · Cited by 27
FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
Garner, E. F., Williams, A. P., Stafman, L. L., Aye, J. M., Mroczek‐Musulman, E., Moore, B. P., Stewart, J. E., Friedman, G. K., & Beierle, E. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-25263-5 · Cited by 26
Weeden, C. E., Holik, A. Z., Young, R. J., Ma, S. B., Garnier, J.-M., Fox, S. B., Antippa, P. N., Irving, L. B., Steinfort, D., Wright, G. M., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0174 · Cited by 25
Will Organoids Fill the Gap towards Functional Precision Medicine?
Papaccio, F., Cabeza-Segura, M., García-Micó, B., Tarazona, N., Roda, D., Castillo, J., & Cervantes, A. M. R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111939 · Cited by 25
Can personalized medicine survive?
Wm, G. (1971) · PubMed · Cited by 22
Pharmacoepigenetics and Pharmacoepigenomics: An Overview
Peedicayil, J. (2018) · Current Drug Discovery Technologies · doi:10.2174/1570163815666180419154633 · Cited by 21
Precision medicine in autoimmune diseases: fact or fiction
Dominguez, D. T., & Alarcón-Riquelme, M. E. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab448 · Cited by 21
Nuotio, M.-L., Tähtisalo, H. S., Lahtinen, A., Donner, K. M., Fyhrquist, F., Perola, M., KONTULA, K. K., & Hiltunen, T. P. (2022) · Epigenetics · doi:10.1080/15592294.2022.2038418 · Cited by 20
The Missing ‐Omes: Proposing Social and Environmental Nomenclature in Precision Medicine
Davis, M., & Shanley, T. P. (2017) · Clinical and Translational Science · doi:10.1111/cts.12453 · Cited by 18
Kirschbaum, A., Geisse, N. C., Judd, S. T., & Meyer, L. M. (1950) · PubMed · Cited by 17
Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma
Kachroo, P., Sordillo, J. E., Lutz, S. M., Weiss, S. T., Kelly, R. S., McGeachie, M. J., Wu, A. C., & Lasky-Su, J. A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111148 · Cited by 17
Kaboli, P. J., Luo, S., Chen, Y., Jomhori, M., İmani, S., Xiang, S., Wu, Z., Li, M., Shen, J., Zhao, Y., et al. (2022) · Gene · doi:10.1016/j.gene.2021.146171 · Cited by 16
Mitochondrial DNA Mutations and Diabetes: Another Step toward Individualized Medicine
Fischel‐Ghodsian, N. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00014 · Cited by 11
Recommendations for pharmacotranscriptomic profiling of drug response in CNS disorders
Xicota, L., Toma, I. D., Maffioletti, E., Pisanu, C., Squassina, A., Baune, B. T., Potier, M., Stacey, D., & Dierssen, M. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.10.005 · Cited by 11
Cited by
Child and adolescent psychiatry: challenges, solutions, opportunities, and future directions
Cortese, S., Arango, C., Aymerich, C., Catalan, A., Chetouani, M., Cohen, D., Coghill, D., Gabellone, A., Iniesta, R., Kadan, A., et al. (2026) · World Psychiatry · doi:10.1002/wps.70044 · Cited by 4
Metadata
- Authors
- Wang, R. C., & Wang, Z.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-07-28
- Volume
- 15
- Issue
- 15
- Pages
- 3837
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4385342688
- Cited by
- 315
- References
- 163
- FWCI
- 30.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.